These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11003751)

  • 1. The influence of human T lymphotropic virus type I infection on the outcome of cardiovascular surgery.
    Masuda H; Moriyama Y; Toda R; Shimokawa S; Iguro Y; Watanabe S; Hisatomi K; Matsumoto H; Taira A
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):699-706. PubMed ID: 11003751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T lymphotropic virus type 1 infection and gastric cancer development in Japan.
    Matsumoto S; Yamasaki K; Tsuji K; Shirahama S
    J Infect Dis; 2008 Jul; 198(1):10-5. PubMed ID: 18544011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human T lymphotropic virus type I infection on the etiology of community-acquired pneumonia.
    Atsumi E; Yara S; Higa F; Hirata T; Haranaga S; Tateyama M; Fujita J
    Intern Med; 2009; 48(12):959-65. PubMed ID: 19525581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
    Kishihara Y; Furusyo N; Kashiwagi K; Mitsutake A; Kashiwagi S; Hayashi J
    J Infect Dis; 2001 Nov; 184(9):1114-9. PubMed ID: 11598833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.
    Arisawa K; Soda M; Akahoshi M; Matsuo T; Nakashima E; Tomonaga M; Saito H
    Jpn J Cancer Res; 1998 Aug; 89(8):797-805. PubMed ID: 9765614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1.
    Gonçalves DU; Guedes AC; Proietti AB; Martins ML; Proietti FA; Lambertucci JR;
    Am J Trop Med Hyg; 2003 May; 68(5):562-5. PubMed ID: 12812346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative distribution of T cell subsets is altered in Jamaican children infected with human T cell lymphotropic virus type I.
    Maloney EM; Pate E; Wiktor SZ; Morais P; Mann D; Gray R; Manns A; Blattner WA
    J Infect Dis; 1995 Sep; 172(3):867-70. PubMed ID: 7658085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-lymphotropic virus type I in Japan.
    Yamaguchi K
    Lancet; 1994 Jan; 343(8891):213-6. PubMed ID: 7904671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.
    Matsuyama W; Kawabata M; Mizoguchi A; Iwami F; Wakimoto J; Osame M
    Clin Exp Immunol; 2003 Sep; 133(3):397-403. PubMed ID: 12930367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation in patients with human T-cell lymphotropic virus type 1.
    Shirai H; Suzuki M; Tomita Y; Iwadoh K; Kai K; Sannomiya A; Koyama I; Nakajima I; Fuchinoue S
    Transplant Proc; 2012 Jan; 44(1):83-6. PubMed ID: 22310586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.
    Murphy EL; Glynn SA; Fridey J; Smith JW; Sacher RA; Nass CC; Ownby HE; Wright DJ; Nemo GJ
    Arch Intern Med; 1999 Jul; 159(13):1485-91. PubMed ID: 10399901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
    Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
    Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus and human T-cell lymphotropic virus type 1 co-infection in the Northern Territory, Australia.
    Marr I; Davies J; Baird RW
    Int J Infect Dis; 2017 May; 58():90-95. PubMed ID: 28315754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features of Breast Cancer Patients with Human T-Cell Lymphotropic Virus Type-1 Infection.
    Hirata M; Shinden Y; Nagata A; Nomoto Y; Saho H; Nakajo A; Arigami T; Kurahara H; Maemura K; Natsugoe S; Kijima Y
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1909-1912. PubMed ID: 31244317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.
    Santos RF; Conceição GC; Martins MS; Kraychete A; Penalva MA; Carvalho EM; Lopes AA; Rocha PN
    BMC Nephrol; 2017 Feb; 18(1):64. PubMed ID: 28202003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers.
    Akimoto M; Kozako T; Sawada T; Matsushita K; Ozaki A; Hamada H; Kawada H; Yoshimitsu M; Tokunaga M; Haraguchi K; Uozumi K; Arima N; Tei C
    J Med Virol; 2007 Jul; 79(7):977-86. PubMed ID: 17516523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.